Reuters logo
BRIEF-3SBio Inc TPIAO being received approval for drug clinical trials
9. Juni 2017 / 07:32 / in 5 Monaten

BRIEF-3SBio Inc TPIAO being received approval for drug clinical trials

June 9 (Reuters) - 3SBio Inc

* TPIAO, one of products of group, has been granted approval for drug clinical trials for additional indications issued by china food and drug administration Source text for Eikon: Further company coverage:

Unsere Werte:Die Thomson Reuters Trust Principles
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below